Question 1

Does JPMorgan Chase own STLN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, JPMorgan Chase holds 409,348 shares of STLN (Starling Oncology), worth $2.3M.

Question 2

How many shares of STLN does JPMorgan Chase own?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase holds 409,348 shares of STLN (Starling Oncology).

Question 3

What is JPMorgan Chase's STLN position worth?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase's STLN position is worth $2.3M.

Question 4

Is JPMorgan Chase buying or selling STLN?

Accepted Answer

In Q2 2026, JPMorgan Chase increased its STLN position by 39,171 shares (+10.6%).

Question 5

When did JPMorgan Chase first buy STLN?

Accepted Answer

JPMorgan Chase already held STLN in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	409,348	+10.6%	$2.3M	0.0%	$5.43	29
2026-Q1	Decreased	370,177	-4.3%	$1M	0.0%	$3.07	0
2025-Q4	Increased	386,778	+1483.3%	$1.4M	0.0%	$3.56	41
2025-Q3	Decreased	24,429	-12.6%	$85,258	0.0%	$3.49	0
2025-Q2	Increased	27,935	+516x	$57,267	0.0%	$2.05	23
2025-Q1	Decreased	54	-67.5%	$62	0.0%	$1.14	0
2024-Q4	Decreased	166	-2.9%	$51	0.0%	$0.31	0
2024-Q3	First report	171	-	$56	0.0%	$0.33	0

STLN8 quarters

STLN
8 quarters